Trial · NCT07906743
Mandala Coloring in Late Pregnancy
NCT07906743, Not applicable, Not yet recruiting, Fidan Balkaya
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mandala Coloring in Late Pregnancy. Trials, record NCT07906743. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906743
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mandala Coloring in Late Pregnancy
- NCT number
- NCT07906743
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 186 participants, estimated
- Lead sponsor
- Fidan Balkaya
- Conditions
- Pregnancy, Anxiety, Depression, Psychological Stress, Sleep Initiation and Maintenance Disorders, Fear of Childbirth
- Interventions
- Mandala Coloring Group
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Depression Score (DASS-21 Depression Subscale) | aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation) | Depression will be assessed with the depression subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe depression. |
| Secondary | Change in Anxiety Score (DASS-21 Anxiety Subscale) | Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation) | Anxiety will be assessed with the anxiety subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe anxiety. |
| Other | Change in Stress Score (DASS-21 Stress Subscale) | Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation) | Stress will be assessed with the stress subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe stress. |
| Other | Change in Insomnia Score (Women's Health Initiative Insomnia Rating Scale) | Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation) | Insomnia symptoms will be assessed with the Women's Health Initiative Insomnia Rating Scale (WHIIRS). The scale consists of 5 items rated on a 5-point Likert scale (0-4), giving a total score range of 0 to 20. Higher scores indicate more severe insomnia symptoms. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906743
GET https://conductscience.org/api/trials/v1/NCT07906743/registered